Form 4 for JBIO Jade Biosciences, Inc.
Accepted 2022-09-14 00:00:00 ET · period of report 2022-09-12 · accession 0001415889-22-009612 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-09-14 | 2022-09-12 | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $2.14 | +7,520 | 7,520 | New | +$16.1K |
| DM | 2022-09-14 | 2022-09-12 | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $17.32 | -7,520 | 0 | -100% | -$130.3K |
| D | 2022-09-14 | 2022-09-12 | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $0.00 | -7,520 | 36.9K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-12 | M | A | 7,520 | $2.14 | 7,520 | D | — | — | |
| 2 | Common | Common Stock | 2022-09-12 | S | D | 5,272 | $16.90 | 2,248 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.59 to $17.58, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2022-09-12 | S | D | 1,976 | $18.26 | 272 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.595 to $18.54, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 4 | Common | Common Stock | 2022-09-12 | S | D | 272 | $18.77 | 0 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.72 to $18.86, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 5 | Derivative | Stock Option (Right to Buy) | 2022-09-12 | M | D | 7,520 | $0.00 | 36,900 | D | $2.14 · — to 2031-04-02 | 7,520 Common Stock | (F5) A total of 48,882 shares subject to an employee stock option were granted on April 2, 2021, with shares vesting in 48 substantially equal monthly installments. |